Back
Keros Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
35
KROS
Keros Therapeutics
Last Price:
55.82
Seasonality Move:
37.33%
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
127.17
Seasonality Move:
0.19%
Sell
35
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $57.32. The Score for KROS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $127.10. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $57.32
The current trend is moderately bullish and KROS is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $127.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.54 | Buy |
Relative Strength Index (14 RSI): | 69.78 | Buy |
Chaikin Money Flow: | 11894 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.63 - 54.93) | Buy |
Bollinger Bands (100): | (44.93 - 54.13) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.72 | Sell |
Relative Strength Index (14 RSI): | 38.7 | Sell |
Chaikin Money Flow: | -11607 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (127.06 - 139.4) | Sell |
Bollinger Bands (100): | (124.44 - 147.62) | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.81 | Buy |
20-day SMA: | 51.2 | Buy |
50-day SMA: | 49.36 | Buy |
200-day SMA: | 52.15 | Buy |
8-day EMA: | 55.34 | Buy |
20-day EMA: | 52.61 | Buy |
50-day EMA: | 50.31 | Buy |
200-day EMA: | 49.54 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.94 | Buy |
20-day SMA: | 132.14 | Sell |
50-day SMA: | 138.1 | Sell |
200-day SMA: | 126.4 | Buy |
8-day EMA: | 126.81 | Buy |
20-day EMA: | 130.43 | Sell |
50-day EMA: | 134.6 | Sell |
200-day EMA: | 128.85 | Sell |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.31 per share, and a decrease next year of $0.43 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Keros Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |